CARETENDERS HEALTH CORP
NT 10-K, 1998-06-30
HOME HEALTH CARE SERVICES
Previous: OPPENHEIMER QUEST CAPITAL VALUE FUND INC, N-30D, 1998-06-30
Next: INDUSTRIAL IMAGING CORP, NT 10-K, 1998-06-30



                  U.S. SECURITIES AND EXCHANGE COMMISSION

                          WASHINGTON, D.C. 20549

                                FORM 12b-25

                        NOTIFICATION OF LATE FILING

                          SEC FILE NUMBER: 1-9848
                         CUSIP NUMBER:  141740209

[x] Form 10-K and /Form 10-KSB  [ ] Form 20-F  [ ] Form 11-K  [ ] Form 10-Q
and Form 10-QSB  [ ] Form N-SAR

     For period ended March 31, 1998

     [ ] Transition Report on Form 10-K
     [ ] Transition Report on Form 20-F
     [ ] Transition Report on Form 11-K
     [ ] Transition Report on Form 10-Q
     [ ] Transition Report on Form N-SAR
     For transition period ended:  Not Applicable



     Read Attached Instruction Sheet Before Preparing Form.   Please Print
or Type.

     Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.


     If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:   Not Applicable



<PAGE>

PART I -- REGISTRANT INFORMATION


     Full Name of Registrant:  Caretenders Health Corp.
     Former Name if Applicable:  Senior Service Corp.
     Address of Principal Executive Office:
          100 Mallard Creek Road, Suite 400
          Louisville, Kentucky 40207


PART II -- RULES 12b-25(b) AND (c)


If the subject report could not be filed without unreasonable effort or
expense and the Registrant seeks relief pursuant to Rule 12b-25, the
following should be completed.
     (Check box if appropriate)

[X]  (a)  The reasons described in reasonable detail in Part III of this
          form could not be eliminated without unreasonable effort or
          expense.

[X]  (b)  The subject Annual Report on Form 10-K, or portion thereof, will
          be filed on or before the fifteenth calendar day following the
          prescribed due date; or the subject quarterly report or
          transition report on Form 10-Q, or portion thereof will be filed
          on or before the fifth calendar day following the prescribed due
          date; and

[ ]  (c)  The accountant's statement or other exhibit required by Rule
          12b-25(c) has been attached if applicable.


PART III -- NARRATIVE


State below in reasonable detail the reasons why Form 10-K and Form 10-KSB,
20-F, 11-K, 10-Q and Form 10-QSB, N-SAR, or the transition report or
portion thereof could not be filed within the prescribed period.

          Certain changes in Medicare reimbursement for home nursing
     services became effective for the Company on April 1, 1998. 
     Management is currently completing its evaluation and related
     disclosures necessary to describe the effect of these changes on
     the Company.  Management has determined that these disclosures
     are spread throughout the Annual Report on Form 10-K.


<PAGE> 

PART IV -- OTHER INFORMATION


     (1)  Name and telephone number of person to contact in regard to this
notification


          C. Steven Guenthner                502/899-5355


     (2)  Have all other periodic reports required under section 13 or
15(d) of the Securities Exchange Act of 1934 or section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for such
shorter period that the registrant was required to file such report(s) been
filed?  If the answer is not, identify report(s).

                                           [X]  Yes       [ ]  No

     (3)  Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report
or portion thereof?

                                           [ ]  Yes       [X]  No

     If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why
a reasonable estimate of the results cannot be made.


     Caretenders Health Corp. has caused this notification to be signed on
its behalf by the undersigned thereunto duly authorized.


Date: June 29, 1998                By:/s/ C. Steven Guenthner

                                      C. Steven Guenthner
                                      Senior Vice President and
                                      Chief Financial Officer





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission